ZYME Zymeworks Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR पर देखें ↗ बंद अक्ट 2, 2026 10-K/10-Q अग 6, 2026
$25.15
· 52 सप्ताह की सीमा का %
· निम्न से ऊपर
· उच्च तक
$16.0052w निम्न
$31.3452w उच्च
मार्केट कैप (MRQ)
$1.80B
P/E (TTM)
-12.5
EPS (TTM)
$-2.02
राजस्व (TTM)
$37M
आपके बैज
52W रेंज
$16–$31
विश्लेषक रेटिंग
BUY
मूल्य लक्ष्य
$41
P/E
-12.5
ROE
-72.3%
शुद्ध लाभ मार्जिन
-404.0%
आपकी बैज स्ट्रिप खाली है — इस पेज पर कहीं भी एक मीट्रिक पिन करें।
ZYME स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$25.15
मार्केट कैप (MRQ)
$1.80B
P/E (TTM)
-12.5
EPS (TTM)
$-2.02
राजस्व (TTM)
$37M
ROE (TTM)
-72.3%
52W रेंज
$16–$31
ZYME स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
सीमा
बार
बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।
Zymeworks Inc. - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver,
British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million. This was the largest Canadian biotech IPO in more than a decade. By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange.
In May 2019, Zymeworks announced that GSK has expanded its 2016 licensing and collaboration agreement for the research, development and commercialization of bispecific antibodies across multiple disease areas. The extended agreement has meant that GSK can have access to Zymeworks' heavy-light chain pairing technology, which enables the development of bispecific and multifunctional therapeutics.
In September 2019, Zymeworks announced that, following their clinical trials, it has been confirmed that their ZW25 monotherapy can provide durable disease control in patients with a variety of HER2-expressing solid tumors that have progressed following standard of care treatments.
In May 2022, Zymeworks rejected an unsolicited takeover proposal from a Dubai hedge fund, All Blue Falcons FZE, an arm of All Blue Capital.
Azymetric
This is an IgG1-based heterodimeric antibody scaffold that consists of two different heavy chains engineered to exclusively assemble into a single molecule, allowing bi-specific binding to two different antigens or drug targets. The Azymetric scaffold is engineered by making amino acid changes in the CH3 region of the constant Fc domain of the IgG1. This scaffold can also be engineered with tailored effector function and optimized serum half-life.
Awards and recognition
Deal of the Year, Lifesciences BC Awards, 2018
Life Sciences Company of the Year, Lifesciences BC Awards, 2016
Emerging company of the year – Health, BIOTECanada Gold Leaf Awards, 2015
12th Place, BC's Leading Innovators, 2011
Life Science Emerging Rocket, 2009, 2010, 2011
Early stage Company of the year – Industrial & Agriculture, BIOTECanada Gold Leaf Awards, 2009
== References ==
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
क्षेत्रHealthcare
उद्योगBiotechnology
कर्मचारी231
देशUS
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व$106M2020-12-31 → 2025-12-31
EPS$-1.082020-12-31 → 2025-12-31
फ्री कैश फ्लो$-35M2023-12-31 → 2025-12-31
शुद्ध मार्जिन-404.0%2023-12-31 → 2025-12-31
मूल्यांकन और अनुपात
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
| मेट्रिक | 5Y रुझान | ZYME | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| P/E (TTM) | -12.55Y औसत ≈-8.8 | ≈-8.8 | · | · | |
| P/S (TTM) | 48.45Y औसत ≈13.8 | ≈13.8 | 10.3 | अति मूल्यांकित | |
| P/B (MRQ) | 22.35Y औसत ≈4.0 | ≈4.0 | 3.7 | अति मूल्यांकित | |
| मूल्य / FCF (TTM) | -14.95Y औसत ≈-24.0 | ≈-24.0 | · | · | |
| मूल्य / नकदी प्रवाह (TTM) | -15.05Y औसत ≈-25.0 | ≈-25.0 | · | · | |
| मूल्य / मूर्त पुस्तक (MRQ) | 22.65Y औसत ≈3.4 | ≈3.4 | · | · |
सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
| मेट्रिक | 5Y रुझान | ZYME | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| परिचालन मार्जिन (TTM) | -419.0%5Y औसत ≈-149.5% | ≈-149.5% | -588.2% | कमजोर | |
| EBITDA Margin (EBITDA मार्जिन) | -87.3%5Y औसत ≈-149.5% | ≈-149.5% | -588.2% | कमजोर | |
| प्रीटैक्स मार्जिन (TTM) | -407.8%5Y औसत ≈-128.3% | ≈-128.3% | -709.2% | कमजोर | |
| शुद्ध लाभ मार्जिन (TTM) | -404.0%5Y औसत ≈-131.2% | ≈-131.2% | -507.2% | कमजोर | |
| ROA (TTM) | -37.2%5Y औसत ≈-21.0% | ≈-21.0% | -29.6% | शीर्ष स्तर | |
| ROE (TTM) | -72.3%5Y औसत ≈-29.5% | ≈-29.5% | -42.0% | शीर्ष स्तर | |
| ROIC | -35.1%5Y औसत ≈-35.7% | ≈-35.7% | · | · |
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
| मेट्रिक | 5Y रुझान | ZYME | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| वर्तमान अनुपात (MRQ) | 6.35Y औसत ≈5.6 | ≈5.6 | 9.0 | कम तरलता | |
| Quick Ratio (त्वरित अनुपात) | 1.15Y औसत ≈3.2 | ≈3.2 | 5.8 | कम तरलता |
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
| मेट्रिक | 5Y रुझान | ZYME | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Revenue YoY (राजस्व YoY) | 38.9%5Y औसत ≈274.4% | ≈274.4% | · | · | |
| Revenue CAGR 3Y (राजस्व CAGR 3Y) | -36.4%5Y औसत ≈10.2% | ≈10.2% | · | · | |
| Revenue CAGR 5Y (राजस्व CAGR 5Y) | 22.2% | · | · | · |
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
| मेट्रिक | 5Y रुझान | ZYME | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Asset Turnover (परिसंपत्ति टर्नओवर) | 0.35Y औसत ≈0.2 | ≈0.2 | 0.2 | शीर्ष स्तर | |
| Receivables Turnover (प्राप्य टर्नओवर) | 3.55Y औसत ≈2.8 | ≈2.8 | · | · | |
| Revenue / Employee (राजस्व / कर्मचारी (रिपोर्ट की गई हेडकाउंट, यफाइनांस)। व्युत्पन्न — संग्रहीत SEC-XBRL अवधारणा नहीं है।) | ≈$458.7K | · | · | · |
मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
-16.9%
अगली रिपोर्ट
नव 04, 2026
| Period | रिपोर्ट | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|---|
| 30 जून 2026 | अग 5, 2026 | $-0.62 | $-0.50 | -25.1% |
| 31 मार्च 2026 | मई 6, 2026 | $-0.59 | $-0.20 | -201.3% |
| 31 दिसमबर 2025 | $-0.55 | $-0.42 | -29.5% | |
| 30 सितमबर 2025 | $-0.26 | $-0.33 | 20.6% | |
| 30 जून 2025 | $0.03 | $-0.50 | 106.0% | |
| 31 मार्च 2025 | $-0.30 | $-0.42 | 28.0% |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $106M | $76M | $76M | $412M | $27M | |
| R&D Expense | · | · | $144M | $209M | $200M | |
| SG&A Expense | $62M | $62M | $70M | $73M | $43M | |
| Operating Expenses | $199M | $213M | $214M | $282M | $242M | |
| Operating Income | $-93M | $-137M | $-138M | $131M | $-216M | |
| Other Non-op | $51.0K | $-218.0K | $291.0K | $-42.0K | $118.0K | |
| Pretax Income | $-80M | $-117M | $-119M | $135M | $-212M | |
| Income Tax | $1M | $6M | $-568.0K | $11M | $-516.0K | |
| Net Income | $-81M | $-123M | $-119M | $124M | $-212M | |
| EPS (Basic) | $-1.08 | $-1.62 | $-1.72 | $1.91 | $-4.11 | |
| EPS (Diluted) | $-1.08 | $-1.62 | $-1.72 | $1.90 | $-4.61 | |
| Shares (Basic) | 75,404,897 | 75,846,681 | 68,863,010 | 65,194,775 | 51,553,869 | |
| Shares (Diluted) | 75,413,396 | 75,878,738 | 68,863,010 | 65,249,184 | 52,131,596 | |
| EBITDA | $-93M | $-137M | $-138M | · | · |
बैलेंस शीट
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $66M | $158M | $401M | $202M | |
| Short-term Investments | · | · | $217M | $91M | $51M | |
| Receivables | $5M | $56M | $19M | $33M | $16M | |
| Prepaid Expense | $15M | $19M | $19M | $19M | $20M | |
| Current Assets | $249M | $300M | $413M | $545M | $288M | |
| PP&E (Net) | $16M | $18M | $20M | $25M | $23M | |
| PP&E (Gross) | $36M | $35M | $41M | $38M | $37M | |
| Accum. Depreciation | $21M | $18M | $21M | $13M | $14M | |
| Goodwill | $12M | $12M | $12M | $12M | $12M | |
| Intangibles | $1M | $5M | $8M | $9M | $4M | |
| Total Assets | $347M | $463M | $581M | $649M | $389M | |
| Accounts Payable | $36M | $60M | $46M | $87M | $63M | |
| Current Liabilities | $42M | $88M | $56M | $96M | $72M | |
| Capital Leases | $15M | $16M | $22M | $25M | $31M | |
| Deferred Tax | $6M | $5M | $3M | $2M | $2M | |
| Other Non-current Liabilities | $278.0K | $923.0K | $2M | $3M | $3M | |
| Total Liabilities | $78M | $124M | $116M | $156M | $140M | |
| Common Stock | $1.11B | $1.02B | $997M | $886M | $741M | |
| Retained Earnings | $-953M | $-830M | $-677M | $-559M | $-683M | |
| AOCI | $-6M | $-7M | $-7M | $-7M | $-7M | |
| Stockholders' Equity | $269M | $339M | $465M | $493M | $249M | |
| Liabilities + Equity | $347M | $463M | $581M | $649M | $389M | |
| Shares Outstanding | 74,638,413 | 68,964,319 | 70,115,997 | 63,059,501 | 46,633,935 |
नकदी प्रवाह
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $28M | $18M | $8M | $4M | $11M | |
| Deferred Tax | $945.0K | $691.0K | $-757.0K | $2M | $-953.0K | |
| Amort. of Intangibles | $4M | $4M | $3M | $1M | $3M | |
| Restructuring | · | · | $0 | · | · | |
| Operating Cash Flow | $-33M | $-110M | $-118M | $144M | $-192M | |
| CapEx | $2M | $2M | $2M | $8M | $12M | |
| Investing Cash Flow | $27M | $39M | $-207M | $-54M | $145M | |
| Stock Issued | $0 | $0 | $26M | $108M | $0 | |
| Stock Repurchased | $42M | $30M | $0 | $0 | · | |
| Net Stock Activity | $-42M | $-30M | $26M | · | · | |
| Financing Cash Flow | $-19M | $-20M | $82M | $109M | $8M | |
| Net Change in Cash | $-25M | $-91M | $-243M | $199M | $-40M | |
| Taxes Paid | $1M | $3M | $165.0K | $10M | · | |
| Free Cash Flow | $-35M | $-112M | $-121M | · | · |
लाभप्रदता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | -87.3% | -179.7% | -181.6% | · | · | |
| Net Margin | -76.6% | -160.8% | -156.1% | · | · | |
| Pretax Margin | -75.3% | -152.8% | -156.9% | · | · | |
| EBITDA Margin | -87.3% | -179.7% | -181.6% | · | · | |
| ROA | -20.0% | -23.5% | -19.3% | · | · | |
| ROE | -26.9% | -34.8% | -26.7% | · | · | |
| ROIC | -35.1% | -42.6% | -29.6% | · | · |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | 3.4 | 7.4 | · | · | |
| Quick Ratio | 1.1 | 1.4 | 7.1 | · | · |
दक्षता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.1 | 0.1 | · | · | |
| Receivables Turnover | 3.5 | 2.0 | 2.9 | · | · |
प्रति शेयर
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $3.60 | $4.91 | $6.63 | · | · | |
| Revenue / Share | $1.41 | $1.01 | $1.10 | · | · | |
| Cash Flow / Share | $-0.44 | $-1.45 | $-1.72 | · | · | |
| Cash / Share | $0.55 | $0.96 | $2.25 | · | · | |
| EPS (TTM) | $-1.08 | $-1.62 | $-1.72 | $1.90 | · |
विकास दरें
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | 38.9% | 0.38% | -81.6% | 1446.0% | -31.5% | |
| Revenue CAGR 3Y | -36.4% | 41.9% | 25.0% | · | · | |
| Revenue CAGR 5Y | 22.2% | · | · | · | · |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $106M | $76M | $76M | $412M | · | |
| Net Income TTM | $-81M | $-123M | $-119M | $124M | · | |
| Market Cap | $1.97B | $1.01B | $729M | · | · | |
| P/E | -24.4 | -9.0 | -6.0 | 4.1 | · | |
| P/S | 18.5 | 13.2 | 9.6 | · | · | |
| P/B | 7.3 | 3.0 | 1.6 | · | · | |
| P / Tangible Book | 7.7 | 3.1 | 1.6 | 1.0 | · | |
| P / Cash Flow | -59.5 | -9.2 | -6.2 | · | · | |
| P / FCF | -56.9 | -9.0 | -6.0 | · | · | |
| Earnings Yield | -4.1% | -11.1% | -16.6% | 24.2% | · |
आय विवरण
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | $2M | $3M | $28M | $49M | $27M | $31M | $16M | $19M | $10M | $17M | $17M | $7M | $36M | $402M | $3M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | $32M | · | $33M | $39M | $46M | · | $37M | |
| SG&A Expense | $19M | $15M | $15M | $14M | $15M | $17M | $16M | $14M | $16M | $16M | $15M | $17M | $22M | $17M | $30M | $16M | |
| Operating Expenses | $47M | $50M | $47M | $50M | $49M | $53M | $53M | $50M | $62M | $48M | $40M | $50M | $61M | $63M | $83M | $53M | |
| Operating Income | $-42M | $-47M | $-44M | $-22M | $-674.0K | $-26M | $-22M | $-34M | $-43M | $-38M | $-23M | $-33M | $-54M | $-27M | $319M | $-50M | |
| Other Non-op | $196.0K | $120.0K | $-18.0K | $26.0K | $-621.0K | $49.0K | $-253.0K | $-37.0K | $53.0K | $19.0K | $-278.0K | $370.0K | $230.0K | $-31.0K | $-27.0K | $-98.0K | |
| Pretax Income | $-45M | $-46M | $-41M | $-18M | $2M | $-22M | $-18M | $-30M | $-38M | $-32M | $-19M | $-28M | $-49M | $-23M | $320M | $-48M | |
| Income Tax | $-273.0K | $-2M | $-270.0K | $1M | $-186.0K | $496.0K | $6M | $226.0K | $68.0K | $75.0K | $-5M | $1M | $2M | $1M | $11M | $-29.0K | |
| Net Income | $-45M | $-44M | $-41M | $-20M | $2M | $-23M | $-24M | $-30M | $-38M | $-32M | $-14M | $-29M | $-51M | $-24M | $309M | $-48M | |
| EPS (Basic) | $-0.62 | $-0.59 | $-0.55 | $-0.26 | $0.03 | $-0.30 | $-0.32 | $-0.39 | $-0.49 | $-0.42 | $-0.19 | $-0.41 | $-0.76 | $-0.36 | $4.78 | $-0.72 | |
| EPS (Diluted) | $-0.62 | $-0.59 | $-0.55 | $-0.26 | $0.03 | $-0.30 | $-0.32 | $-0.39 | $-0.49 | $-0.42 | $-0.18 | $-0.41 | $-0.76 | $-0.37 | $4.78 | $-0.72 | |
| Shares (Basic) | 72,993,313 | 74,668,790 | · | 75,767,778 | 75,337,168 | 75,171,020 | · | 76,128,531 | 76,392,593 | 76,214,833 | · | 70,575,773 | 67,281,028 | 66,739,308 | · | 66,477,016 | |
| Shares (Diluted) | 72,993,313 | 74,694,762 | · | 75,775,214 | 77,378,449 | 75,226,387 | · | 76,157,101 | 76,396,217 | 76,248,158 | · | 70,575,773 | 67,284,511 | 66,742,030 | · | 66,478,157 | |
| EBITDA | $-42M | $-47M | · | $-22M | $-674.0K | $-26M | · | $-34M | $-43M | $-38M | · | $-33M | $-54M | $-27M | · | $-50M |
बैलेंस शीट
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $179M | $244M | $41M | $65M | $98M | $76M | $66M | $122M | $71M | $115M | · | $94M | $142M | $182M | · | $96M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $201M | $198M | $159M | · | $70M | |
| Receivables | $6M | $5M | $5M | $29M | $3M | $25M | $56M | $24M | $32M | $31M | · | $67M | $49M | $67M | · | $7M | |
| Prepaid Expense | $22M | $16M | $15M | $10M | $12M | $17M | $19M | $23M | $21M | $18M | · | $12M | $31M | $19M | · | $18M | |
| Current Assets | $298M | $386M | $249M | $292M | $296M | $306M | $300M | $344M | $383M | $394M | · | $375M | $420M | $426M | · | $191M | |
| PP&E (Net) | $14M | $15M | $16M | $16M | $16M | $17M | $18M | $18M | $18M | $19M | · | $21M | $22M | $24M | · | $26M | |
| PP&E (Gross) | · | · | $36M | · | · | · | $35M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $21M | · | · | · | $18M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | · | $12M | $12M | $12M | · | $12M | |
| Intangibles | $998.0K | $1M | $1M | $1M | $2M | $3M | $5M | $6M | $7M | $7M | · | $8M | $7M | $8M | · | $9M | |
| Total Assets | $397M | $478M | $347M | $397M | $408M | $426M | $463M | $487M | $516M | $554M | · | $556M | $602M | $601M | · | $300M | |
| Accounts Payable | $27M | $30M | $36M | $34M | $31M | $38M | $60M | $52M | $44M | $47M | · | $68M | $70M | $59M | · | $52M | |
| Current Liabilities | $47M | $36M | $42M | $42M | $39M | $65M | $88M | $84M | $55M | $57M | · | $73M | $94M | $67M | · | $58M | |
| Capital Leases | $13M | $14M | $15M | $16M | $15M | $15M | $16M | $17M | $17M | $21M | · | $22M | $23M | $24M | · | $25M | |
| Deferred Tax | $4M | $4M | $6M | $5M | $5M | $5M | $5M | $3M | $3M | $3M | · | $2M | $2M | $2M | · | $2M | |
| Other Non-current Liabilities | $278.0K | $278.0K | $278.0K | $278.0K | $828.0K | $856.0K | $923.0K | $929.0K | $1M | $2M | · | $2M | $4M | $4M | · | $3M | |
| Total Liabilities | $317M | $315M | $78M | $77M | $74M | $101M | $124M | $120M | $109M | $116M | · | $132M | $153M | $127M | · | $121M | |
| Common Stock | $1.13B | $1.13B | $1.11B | $1.09B | $1.07B | $1.02B | $1.02B | $1.01B | $1.01B | $1.00B | · | $932M | $929M | $900M | · | $885M | |
| Retained Earnings | $-1.17B | $-1.07B | $-953M | $-886M | $-851M | $-853M | $-830M | $-798M | $-747M | $-709M | · | $-663M | $-634M | $-583M | · | $-868M | |
| AOCI | $-7M | $-7M | $-6M | $-6M | $-6M | $-6M | $-7M | $-6M | $-8M | $-8M | · | $-8M | $-8M | $-6M | · | $-7M | |
| Stockholders' Equity | $80M | $164M | $269M | $320M | $335M | $325M | $339M | $367M | $406M | $438M | $465M | $424M | $449M | $474M | $493M | $180M | |
| Liabilities + Equity | $397M | $478M | $347M | $397M | $408M | $426M | $463M | $487M | $516M | $554M | · | $556M | $602M | $601M | · | $300M | |
| Shares Outstanding | 71,412,072 | 73,102,689 | 74,638,413 | 75,139,281 | 74,846,147 | 69,584,811 | 68,964,319 | 69,584,882 | 70,831,545 | 70,677,106 | · | 67,922,559 | 67,687,384 | 64,083,770 | · | 61,694,387 |
नकदी प्रवाह
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $7M | $9M | $7M | $6M | $6M | $5M | $5M | $5M | $4M | $3M | $2M | $367.0K | $2M | $4M | $5M | |
| Amort. of Intangibles | $176.0K | $176.0K | $185.0K | $648.0K | $2M | $2M | $2M | $980.0K | $812.0K | $702.0K | $673.0K | $672.0K | $678.0K | $679.0K | $529.0K | $166.0K | |
| Operating Cash Flow | $-32M | $-46M | $-10M | $-31M | $12M | $-3M | $-42M | $-6M | $-25M | $-38M | $14M | $-43M | $-6M | $-83M | $327M | $-73M | |
| CapEx | $0 | $216.0K | $581.0K | $410.0K | $514.0K | $16.0K | $314.0K | $899.0K | $593.0K | $185.0K | $356.0K | $930.0K | $802.0K | $386.0K | $348.0K | $981.0K | |
| Investing Cash Flow | $17M | $70M | $5M | $368.0K | $9M | $12M | $-6M | $72M | $-20M | $-7M | $-1M | $-7M | $-61M | $-138M | $-22M | $-30M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | $26M | $0 | $0 | $0 | |
| Stock Repurchased | $52M | $76M | $25M | $16M | $0 | $0 | $9M | · | · | · | $0 | · | · | · | · | · | |
| Net Stock Activity | · | $-76M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-50M | $179M | $-19M | $-2M | $1M | $1M | $-9M | $-15M | $1M | $2M | $51M | $2M | $28M | $2M | $-377.0K | $628.0K | |
| Net Change in Cash | $-65M | $203M | $-24M | $-33M | $22M | $10M | $-56M | $51M | $-44M | $-43M | $63M | $-48M | $-39M | $-219M | $305M | $-103M | |
| Taxes Paid | $863.0K | $245.0K | $107.0K | $660.0K | $196.0K | $387.0K | $3M | $106.0K | $106.0K | $0 | · | · | · | · | · | · | |
| Free Cash Flow | · | $-46M | · | · | · | $-3M | · | · | · | $-38M | · | · | · | $-84M | · | · |
लाभप्रदता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -919.0% | -1956.7% | · | -80.1% | -1.4% | -94.5% | · | -213.8% | -222.9% | -376.9% | · | -201.4% | -772.8% | -76.7% | · | -1914.0% | |
| Net Margin | -980.8% | -1834.0% | · | -71.0% | 4.8% | -83.5% | · | -186.6% | -195.8% | -315.6% | · | -173.8% | -730.5% | -68.5% | · | -1818.6% | |
| Pretax Margin | -986.8% | -1925.0% | · | -66.1% | 4.4% | -81.7% | · | -185.2% | -195.5% | -314.8% | · | -167.1% | -706.9% | -64.5% | · | -1819.7% | |
| EBITDA Margin | -919.0% | -1956.7% | · | -80.1% | -1.4% | -94.5% | · | -213.8% | -222.9% | -376.9% | · | -201.4% | -772.8% | -76.7% | · | -1914.0% | |
| ROA | -11.2% | -9.8% | · | -4.4% | 0.50% | -4.6% | · | -5.7% | -6.7% | -5.5% | · | -6.7% | -17.0% | -8.1% | · | -31.9% | |
| ROE | -21.7% | -18.1% | · | -5.7% | 0.63% | -5.9% | · | -7.5% | -8.8% | -6.9% | · | -9.5% | -22.8% | -10.3% | · | -53.2% | |
| ROIC | -52.2% | -27.4% | · | -7.4% | -0.22% | -8.1% | · | -9.4% | -10.6% | -8.6% | · | -8.2% | -12.5% | -6.1% | · | -28.0% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.3 | 10.8 | · | 6.9 | 7.7 | 4.7 | · | 4.1 | 7.0 | 6.9 | · | 5.1 | 4.5 | 6.3 | · | 3.3 | |
| Quick Ratio | 3.9 | 7.0 | · | 2.2 | 2.6 | 1.5 | · | 1.7 | 1.9 | 2.6 | · | 5.0 | 4.2 | 6.1 | · | 3.0 |
दक्षता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | |
| Receivables Turnover | 1.1 | 0.2 | · | 1.0 | 2.8 | 1.0 | · | 0.4 | 0.5 | 0.2 | · | 0.4 | 0.3 | 1.1 | · | 0.8 |
प्रति शेयर
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.13 | $2.24 | · | $4.26 | $4.47 | $4.67 | · | $5.27 | $5.73 | $6.20 | · | $6.25 | $6.63 | $7.39 | · | $2.91 | |
| Revenue / Share | $0.06 | $0.03 | · | $0.36 | $0.63 | $0.36 | · | $0.21 | $0.25 | $0.13 | · | $0.23 | $0.10 | $0.53 | · | $0.04 | |
| Cash Flow / Share | · | $-0.61 | · | · | · | $-0.05 | · | · | · | $-0.49 | · | · | · | $-1.25 | · | · | |
| Cash / Share | $2.51 | $3.34 | · | $0.86 | $1.31 | $1.10 | · | $1.76 | $1.00 | $1.62 | · | $1.39 | $2.10 | $2.83 | · | $1.56 | |
| EPS (TTM) | $-2.02 | $-1.37 | · | $-0.85 | $-0.98 | $-1.50 | · | $-1.48 | $-1.50 | $-1.77 | · | $3.24 | $2.93 | $2.72 | · | $-3.83 |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $37M | $81M | · | $134M | $123M | $93M | · | $62M | $63M | $50M | · | $462M | $448M | $446M | · | $30M | |
| Net Income TTM | $-150M | $-103M | · | $-63M | $-74M | $-114M | · | $-114M | $-113M | $-126M | · | $205M | $186M | $173M | · | $-224M | |
| Market Cap | $1.87B | $1.83B | · | $1.28B | $939M | $829M | · | $873M | $603M | $744M | · | $431M | $585M | $579M | · | $379M | |
| P/E | -12.9 | -18.3 | · | -20.1 | -12.8 | -7.9 | · | -8.5 | -5.7 | -5.9 | · | 2.0 | 2.9 | 3.3 | · | -1.6 | |
| P/S | 50.3 | 22.5 | · | 9.5 | 7.6 | 8.9 | · | 14.0 | 9.6 | 14.7 | · | 0.9 | 1.3 | 1.3 | · | 12.7 | |
| P/B | 23.2 | 11.2 | · | 4.0 | 2.8 | 2.6 | · | 2.4 | 1.5 | 1.7 | · | 1.0 | 1.3 | 1.2 | · | 2.1 | |
| P / Tangible Book | 27.7 | 12.2 | · | 4.2 | 2.9 | 2.7 | · | 2.5 | 1.6 | 1.8 | · | 1.1 | 1.4 | 1.3 | · | 2.4 | |
| P / Cash Flow | · | -40.0 | · | · | · | -243.3 | · | · | · | -19.7 | · | · | · | -7.0 | · | · | |
| Earnings Yield | -7.7% | -5.5% | · | -5.0% | -7.8% | -12.6% | · | -11.8% | -17.6% | -16.8% | · | 51.1% | 33.9% | 30.1% | · | -62.3% |
सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| राजस्व | $106M | $76M | $76M | $412M | $27M |
| परिचालन मार्जिन % | -87.3% | -179.7% | -181.6% | · | · |
| शुद्ध आय | $-81M | $-123M | $-119M | $124M | $-212M |
| तनुकरणित EPS | $-1.08 | $-1.62 | $-1.72 | $1.90 | $-4.61 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| वर्तमान अनुपात | 5.9 | 3.4 | 7.4 | · | · |
| त्वरित अनुपात | 1.1 | 1.4 | 7.1 | · | · |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $-35M | $-112M | $-121M | · | · |
संस्थागत मालिक (13F) 212 फाइलर्स · $1.9B कुल · तिथि अनुसार 30 जून 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
धारक
212
धारित मूल्य
$1.9B
नई स्थितियाँ
22
बाहर निकली पोजीशन
31
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 22 (-20 पिछली तिमाही की तुलना में) | 31 (0 पिछली तिमाही की तुलना में) | 59 (-16 पिछली तिमाही की तुलना में) | 73 (+13 पिछली तिमाही की तुलना में) | -2.0M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| EcoR1 Capital, LLC | $600445942 | 22970388 | 32.29% | शेयर |
| Rubric Capital Management LP | $182980000 | 7000000 | 9.84% | शेयर |
| BlackRock, Inc. | $111121925 | 4251030 | 5.98% | शेयर |
| PERCEPTIVE ADVISORS LLC | $109342391 | 4182953 | 5.88% | शेयर |
| BVF INC/IL | $95388572 | 3649142 | 5.13% | शेयर |
| VANGUARD GROUP INC | $61315382 | 2328727 | 3.30% | शेयर |
| MORGAN STANLEY | $58325141 | 2231260 | 3.14% | शेयर |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $46558373 | 1781116 | 2.50% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $40752208 | 1558998 | 2.19% | शेयर |
| Assenagon Asset Management S.A. | $32727986 | 1252027 | 1.76% | शेयर |
| Nextech Invest Ltd. | $29118548 | 1113946 | 1.57% | शेयर |
| STATE STREET CORP | $28445966 | 1088216 | 1.53% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $25995770 | 994955 | 1.40% | शेयर |
| CITADEL ADVISORS LLC | $23895516 | 914136 | 1.29% | शेयर |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $23259000 | 889802 | 1.25% | शेयर |
| FMR LLC | $18365133 | 702568 | 0.99% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $18099012 | 692410 | 0.97% | शेयर |
| Prosight Management, LP | $17629705 | 674434 | 0.95% | शेयर |
| Qube Research & Technologies Ltd | $15516443 | 593590 | 0.83% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13332236 | 510032 | 0.72% | शेयर |
| Redmile Group, LLC | $12851836 | 491654 | 0.69% | शेयर |
| Capricorn Fund Managers Ltd | $12717868 | 486529 | 0.68% | शेयर |
| GOLDMAN SACHS GROUP INC | $12307288 | 470822 | 0.66% | शेयर |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $10939512 | 418497 | 0.59% | शेयर |
| DEUTSCHE BANK AG\ | $10382547 | 397190 | 0.56% | शेयर |
| Hillsdale Investment Management Inc. | $10009581 | 382922 | 0.54% | शेयर |
| FIRST TRUST ADVISORS LP | $8897088 | 340363 | 0.48% | शेयर |
| Granahan Investment Management, LLC | $8787144 | 336157 | 0.47% | शेयर |
| NORTHERN TRUST CORP | $8392849 | 321073 | 0.45% | शेयर |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $7997401 | 319385 | 0.43% | शेयर |
| Pictet Asset Management Holding SA | $7446189 | 308187 | 0.40% | शेयर |
| PICTON MAHONEY ASSET MANAGEMENT | $7092908 | 271343 | 0.38% | शेयर |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $5849243 | 223766 | 0.31% | शेयर |
| BANK OF AMERICA CORP /DE/ | $5726515 | 219071 | 0.31% | शेयर |
| WELLS FARGO & COMPANY/MN | $5677573 | 217199 | 0.31% | शेयर |
| SummitTX Capital, L.P. | $5510364 | 210802 | 0.30% | शेयर |
| Man Group plc | $5509763 | 210779 | 0.30% | शेयर |
| FEDERATED HERMES, INC. | $4914190 | 187995 | 0.26% | शेयर |
| RAYMOND JAMES FINANCIAL INC | $4350114 | 166416 | 0.23% | शेयर |
| STATE OF WISCONSIN INVESTMENT BOARD | $4066835 | 155579 | 0.22% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3984154 | 152416 | 0.21% | शेयर |
| KENNEDY CAPITAL MANAGEMENT LLC | $3800390 | 145386 | 0.20% | शेयर |
| D. E. Shaw & Co., Inc. | $3785255 | 144807 | 0.20% | शेयर |
| DIADEMA PARTNERS LP | $3715330 | 142132 | 0.20% | शेयर |
| CITIGROUP INC | $3435868 | 131441 | 0.18% | शेयर |
| Bank of New York Mellon Corp | $3427107 | 131106 | 0.18% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3408656 | 130400 | 0.18% | कॉल ऑप्शन |
| XTX Topco Ltd | $3290425 | 125877 | 0.18% | शेयर |
| Nuveen, LLC | $3120829 | 119389 | 0.17% | शेयर |
| PANAGORA ASSET MANAGEMENT INC | $3100282 | 118603 | 0.17% | शेयर |
कार्यकर्ता और 5%+ मालिक 2 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC, Oleg Nodelman, EcoR1 Capital Fund Qualified, L.P. ×8 फाइलिंग | 19 नवमबर 2025 | 30.70% | संशोधन | बोर्ड अभियान | SEC |
| All Blue Falcons FZE, Daniel Edward Llewellen Cookson ×2 फाइलिंग | 28 दिसमबर 2022 | · | प्रारंभिक फाइलिंग | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
कंपनी के अंदरूनी सूत्र 28 इनसाइडर्स · 12 अधिकारी · 17 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Kenneth Galbraith | Chair & CEO | 12 जनवरी 2026 A | 226842 | 0 | 4 | $-3337929 |
| Kristin Stafford | EVP, Chief Financial Officer | 6 अप्रैल 2026 A | · | 0 | 0 | $0 |
| Christopher Astle | SVP & Chief Financial Officer | 5 जनवरी 2024 A | 6503 | 0 | 0 | $0 |
| Neil A Klompas | President & COO | 10 मार्च 2023 M | 17032 | 0 | 0 | $0 |
| Mark Hollywood | EVP & Chief Operating Officer | 6 जुलाई 2026 A | 133852 | 0 | 1 | $-138740 |
| Paul R Schneider | EVP, General Counsel | 13 मई 2026 A | · | 0 | 0 | $0 |
| Adam Schayowitz | EVP, Head of Research & Development | 9 अप्रैल 2026 A | · | 0 | 0 | $0 |
| Scott Platshon | EVP, Chief Business Officer | 9 अप्रैल 2026 A | · | 0 | 0 | $0 |
| Paul Andrew Moore | Chief Scientific Officer | 12 जनवरी 2026 A | 48497 | 0 | 3 | $-721486 |
| Jeffrey T L Smith | EVP & Chief Medical Officer | 12 जनवरी 2026 M | 26708 | 0 | 2 | $-475562 |
| Leone D Patterson | EVP, Chief Bus & Fin Officer | 6 जनवरी 2026 A | 459 | 0 | 0 | $0 |
| Neil Josephson | Chief Medical Officer | 10 नवमबर 2022 M | 14449 | 0 | 0 | $0 |
| Gregory A. Ciongoli | निदेशक | 12 जनवरी 2026 A | 488500 | 0 | 0 | $0 |
| Alessandra Cesano | निदेशक | 12 जनवरी 2026 A | · | 0 | 0 | $0 |
| Carlos Campoy | निदेशक | 12 जनवरी 2026 A | · | 0 | 0 | $0 |
| Robert E Landry | निदेशक | 12 जनवरी 2026 A | · | 0 | 0 | $0 |
| Kelvin Neu | निदेशक | 12 जनवरी 2026 A | · | 0 | 0 | $0 |
| Susan Mahony | निदेशक | 12 जनवरी 2026 A | · | 0 | 0 | $0 |
| Brian N Cherry | निदेशक | 12 जनवरी 2026 A | · | 0 | 0 | $0 |
| EcoR1 Capital, LLC | निदेशक | 17 जनवरी 2025 P | 15720161 | 0 | 0 | $0 |
| Nancy Davidson | निदेशक | 10 दिसमबर 2024 A | · | 0 | 0 | $0 |
| Neil Gallagher | निदेशक | 10 दिसमबर 2024 A | · | 0 | 0 | $0 |
| Derek John Michael Miller | निदेशक | 10 दिसमबर 2024 A | · | 0 | 0 | $0 |
| Troy Cox | निदेशक | 10 दिसमबर 2024 A | · | 0 | 0 | $0 |
| Kenneth J. Hillan | निदेशक | 7 दिसमबर 2023 A | · | 0 | 0 | $0 |
| Hollings Renton | निदेशक | 7 दिसमबर 2023 A | · | 0 | 0 | $0 |
| Natalie Sacks | निदेशक | 21 दिसमबर 2022 A | · | 0 | 0 | $0 |
| Lota S. Zoth | निदेशक | 21 दिसमबर 2022 A | · | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 30 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1.32% | 59315 NS | 31 जुलाई 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.15% | 14705 SH | 1 अक्टूबर 2026 | दैनिक |
| IBB · iShares Trust | 0.14% | 537742 SH | 11 सितमबर 2026 | दैनिक |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.12% | 5008 SH | 1 अक्टूबर 2026 | दैनिक |
| FYC · First Trust Exchange-Traded AlphaDE… | 0.11% | 65877 NS | 31 जुलाई 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.10% | 74514 SH | 19 अगस्त 2026 | दैनिक |
| IWO · iShares Trust | 0.08% | 439290 SH | 11 सितमबर 2026 | दैनिक |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.07% | 50443 SH | 19 अगस्त 2026 | दैनिक |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.07% | 68050 SH | 1 अक्टूबर 2026 | दैनिक |
| IWM · iShares Trust | 0.04% | 1202863 SH | 11 सितमबर 2026 | दैनिक |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.04% | 270692 SH | 19 अगस्त 2026 | दैनिक |
| RSSL · Global X Funds | 0.03% | 22528 NS | 31 जुलाई 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.03% | 189632 NS | 31 जुलाई 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.02% | 5969 NS | 31 जुलाई 2026 | N-PORT |
| ISCG · iShares Trust | 0.02% | 5910 SH | 11 सितमबर 2026 | दैनिक |
| FHLC · FIDELITY COVINGTON TRUST | 0.01% | 18267 NS | 31 जुलाई 2026 | N-PORT |
| WSML · iShares Trust | 0.01% | 3039 SH | 11 सितमबर 2026 | दैनिक |
| VHT · VANGUARD WORLD FUND | 0.01% | 110298 SH | 19 अगस्त 2026 | दैनिक |
| TILT · FlexShares Trust | 0.01% | 5508 NS | 31 जुलाई 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 70572 NS | 31 जुलाई 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 3968 NS | 31 जुलाई 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 12951 NS | 31 जुलाई 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 14406 SH | 10 सितमबर 2026 | दैनिक |
| DFUS · Dimensional ETF Trust | 0.00% | 8364 NS | 31 जुलाई 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 130 NS | 31 जुलाई 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1508613 SH | 19 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 4085 SH | 19 अगस्त 2026 | दैनिक |
| ISCB · iShares Trust | · | 1999 SH | 11 सितमबर 2026 | दैनिक |
| ISCV · iShares Trust | · | 5753 SH | 11 सितमबर 2026 | दैनिक |
| SMMV · iShares Trust | · | 16029 SH | 19 अगस्त 2026 | दैनिक |
ZYME विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
रेटिंग · 18 विश्लेषक
खरीदें
मध्यिका लक्ष्य
$38.00
+51.1%
6 33.3%
मजबूत खरीद
11 61.1%
खरीदें
1 5.6%
होल्ड
0 0.0%
बेचें
0 0.0%
मजबूत बिक्री
12-महीने का मूल्य लक्ष्य
13 विश्लेषक · 2026-09-27माध्य लक्ष्य $41.23 +63.9%
← सभी लक्ष्यों से नीचे
वर्तमान मूल्य $25.15
निम्न$32.00
माध्य$41.23
उच्च$60.00
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
स्रोत: SEC 10-Q अग 6, 2026 को फाइल किया गया